Leverage our bioanalytic services to rapidly profile and evaluate your agent’s biological properties. Discover our full pharmacology and bioanalysis platform including in vivo PK services for both small molecules and biologics.
Study unique immune-related adverse events (irAEs) associated with immunotherapies, using HuGEMM™ and HuCELL™ human target knock-in models.
Assess potential adverse side effects as standalone assessments in cardiovascular, metabolic or renal systems, or embed them within our overall toxicological profiling.
Understand biological structure and its impact on efficacy with various protein expression platforms including mammalian cells, E. coli strains, virus, insect cells, and yeast cells.
Use our comprehensive tool set including RNAi, gene cloning and stable transfection, RT-PCR and reporter gene assays to determine the biological functions of your cancer target.